Publications
Articles
Representing and Reasoning with Temporal Constraints in Clinical Trials Using Semantic Technologies
(2009). Biomedical Engineering Systems and Technologies Springer Berlin Heidelberg, Apr (78), Suppl 1:S77-85. http://dx.doi.org/10.1016/j.ijmedinf.2008.07.013, PMID: 18789876
Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK
[Reprint] [PubMed]
[Citation View]
Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK (2009). Representing and Reasoning with Temporal Constraints in Clinical Trials Using Semantic Technologies. Biomedical Engineering Systems and Technologies Springer Berlin Heidelberg, Apr (78), Suppl 1:S77-85.
Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring
(2009). Am J Transplant, 9 (5), 1087-98. http://dx.doi.org/10.1111/j.1600-6143.2009.02581.x, PMID: 19344431
Knechtle SJ, Pascual J, Bloom DD, Torrealba JR, Jankowska-Gan E, Burlingham WJ, Kwun J, Colvin RB, Seyfert-Margolis V, Bourcier K, Sollinger HW
[Reprint] [PubMed]
[Citation View]
Knechtle SJ, Pascual J, Bloom DD, Torrealba JR, Jankowska-Gan E, Burlingham WJ, Kwun J, Colvin RB, Seyfert-Margolis V, Bourcier K, Sollinger HW (2009). Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. Am J Transplant, 9 (5), 1087-98.
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years
(2009). Clin Immunol, 132 (2), 166-73. http://dx.doi.org/10.1016/j.clim.2009.04.007, PMID: 19443276, PMCID: PMC2735402
Herold KC, Gitelman S, Greenbaum C, Puck J, Hagopian W, Gottlieb P, Sayre P, Bianchine P, Wong E, Seyfert-Margolis V, Bourcier K, Bluestone JA, ImmuneTolerance Network ITN007AI Study Group
[Reprint] [PubMed]
[Citation View]
Herold KC, Gitelman S, Greenbaum C, Puck J, Hagopian W, Gottlieb P, Sayre P, Bianchine P, Wong E, Seyfert-Margolis V, Bourcier K, Bluestone JA, ImmuneTolerance Network ITN007AI Study Group (2009). Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. Clin Immunol, 132 (2), 166-73.
Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes
(2009). J Clin Endocrinol Metab, 94 (2), 504-10. http://dx.doi.org/10.1210/jc.2007-2694, PMID: 19050058, PMCID: PMC2646512
Yu J, Steck AK, Babu S, Yu L, Miao D, McFann K, Hutton J, Eisenbarth GS, Klingensmith G
[Reprint] [PubMed]
[Citation View]
Yu J, Steck AK, Babu S, Yu L, Miao D, McFann K, Hutton J, Eisenbarth GS, Klingensmith G (2009). Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes. J Clin Endocrinol Metab, 94 (2), 504-10.
Murine high specificity/sensitivity competitive europium insulin autoantibody assay
(2009). Diabetes Technol Ther, 11 (4), 227-33. http://dx.doi.org/10.1089/dia.2008.0072, PMID: 19344197, PMCID: PMC2903340
Babaya N, Liu E, Miao D, Li M, Yu L, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Babaya N, Liu E, Miao D, Li M, Yu L, Eisenbarth GS (2009). Murine high specificity/sensitivity competitive europium insulin autoantibody assay. Diabetes Technol Ther, 11 (4), 227-33.
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
(2009). BMC Immunol, 28 (10), 52. http://dx.doi.org/10.1186/1471-2172-10-52, PMID: 19785746, PMCID: PMC2761376
de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V
[Reprint] [PubMed]
[Citation View]
de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V (2009). Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol, 28 (10), 52.
B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans
(2009). Am J Transplant, 9 (9), 2126-35. http://dx.doi.org/10.1111/j.1600-6143.2009.02738.x, PMID: 19624570, PMCID: PMC2837587
Porcheray F, Wong W, Saidman Sl, De Vito J, Girouard TC, Chittenden M, Shaffer J, Tolkoff-Rubin N, Dey BR, Spitzer TR, Colvin RB, Cosimi AB, Kawai T, Sachs DH, Sykes M, Zorn E
[Reprint] [PubMed]
[Citation View]
Porcheray F, Wong W, Saidman Sl, De Vito J, Girouard TC, Chittenden M, Shaffer J, Tolkoff-Rubin N, Dey BR, Spitzer TR, Colvin RB, Cosimi AB, Kawai T, Sachs DH, Sykes M, Zorn E (2009). B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant, 9 (9), 2126-35.
HLA-Mismatched renal transplantation without maintenance immunosuppression
(2008). N Engl J Med, 358 (4), 353-61. http://dx.doi.org/10.1056/NEJMoa071074, PMID: 18216355, PMCID: PMC2819046
Kawai, T, Cosimi AB, Spitzer TR, Tolkoff-Rubin, N, Suthanthiran M, Saidman Sl, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DSC, Hertl M, Goes NB, Wong W, Williams WW, Colvin RB, Sykes M, Sachs DH
[Reprint] [PubMed]
[Citation View]
Kawai, T, Cosimi AB, Spitzer TR, Tolkoff-Rubin, N, Suthanthiran M, Saidman Sl, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DSC, Hertl M, Goes NB, Wong W, Williams WW, Colvin RB, Sykes M, Sachs DH (2008). HLA-Mismatched renal transplantation without maintenance immunosuppression. N Engl J Med, 358 (4), 353-61.
CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial
(2008). Neurology, 71 (12), 917-24. http://dx.doi.org/10.1212/01.wnl.0000325915.00112.61, PMID: 18794494
Viglietta V, Bourcier K, Buckle GJ, Healy B, Weiner HL, Hafler DA, Egorova S, Guttmann CRG, Rusche JR, Khoury SJ
[Reprint] [PubMed]
[Citation View]
Viglietta V, Bourcier K, Buckle GJ, Healy B, Weiner HL, Hafler DA, Egorova S, Guttmann CRG, Rusche JR, Khoury SJ (2008). CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial. Neurology, 71 (12), 917-24.
Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity
(2008). J Allergy Clin Immunol, 121 (5), 1120-5. http://dx.doi.org/10.1016/j.jaci.2008.01.072, PMID: 18374405
Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, Till SJ
[Reprint] [PubMed]
[Citation View]
Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, Till SJ (2008). Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol, 121 (5), 1120-5.
Retrospective tissue typeing of the kidney donor from recipient urine
(2008). Kidney Int, 74 (7), 952-5. http://dx.doi.org/10.1038/ki.2008.340, PMID: 18633344
Srikantha M, Sergeant R, Khan T, Lechler RI, Davey N, Hernandez-Fuentes MP, Warrens AN
[Reprint] [PubMed]
[Citation View]
Srikantha M, Sergeant R, Khan T, Lechler RI, Davey N, Hernandez-Fuentes MP, Warrens AN (2008). Retrospective tissue typeing of the kidney donor from recipient urine. Kidney Int, 74 (7), 952-5.
Knowledge-data integration for temporal reasoning in a clinical trial system
(2008). Int J Med Inform, 78 (1), S77-85. http://dx.doi.org/10.1016/j.ijmedinf.2008.07.013, PMID: 18789876
O'Connor MJ, Shankar RD, Parrish DB, Das AK
[Reprint] [PubMed]
[Citation View]
O'Connor MJ, Shankar RD, Parrish DB, Das AK (2008). Knowledge-data integration for temporal reasoning in a clinical trial system. Int J Med Inform, 78 (1), S77-85.
MIFlowCyt: the minimum information about a Flow Cytometry Experiment
(2008). Cytometry, 73 (10), 926-30. http://dx.doi.org/10.1002/cyto.a.20623, PMID: 18752282, PMCID: PMC2773297
Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, Gasparetto M, Goldberg M, Goralczyk EM, Hyun B, Jansen K, Kollmann T, Kong M, Leif R, McWeeney S, Moloshok TD, Moore W, Nolan G, Nolan J, Nikolich-Zugich J, Parrish D, Purcell B, Qian Y, Selvaraj B, Smith C, Tchuvatkina O, Wertheimer A, Wilkinson P, Wilson C, Wood J, Zigon R; International Society for Advancement of Cytometry Data Standards Task Force, Scheuermann RH, Brinkman RR
[Reprint] [PubMed]
[Citation View]
Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, Gasparetto M, Goldberg M, Goralczyk EM, Hyun B, Jansen K, Kollmann T, Kong M, Leif R, McWeeney S, Moloshok TD, Moore W, Nolan G, Nolan J, Nikolich-Zugich J, Parrish D, Purcell B, Qian Y, Selvaraj B, Smith C, Tchuvatkina O, Wertheimer A, Wilkinson P, Wilson C, Wood J, Zigon R; International Society for Advancement of Cytometry Data Standards Task Force, Scheuermann RH, Brinkman RR (2008). MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry, 73 (10), 926-30.
Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation
(2008). BMC Genomics, 10 (9), 474. http://dx.doi.org/10.1186/1471-2164-9-474, PMID: 18847473, PMCID: PMC2573897
Asare AL, Kolchinsky SA, Gao Z, Wang R, Raddassi K, Bourcier K, Seyfert-Margolis V
[Reprint] [PubMed]
[Citation View]
Asare AL, Kolchinsky SA, Gao Z, Wang R, Raddassi K, Bourcier K, Seyfert-Margolis V (2008). Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation. BMC Genomics, 10 (9), 474.
Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?
(2008). Curr Opin Organ Transplant, 13 (5), 506-12. http://dx.doi.org/10.1097/MOT.0b013e328310b0f7, PMID: 19060534, PMCID: PMC2727645
Feng S
[Reprint] [PubMed]
[Citation View]
Feng S (2008). Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?. Curr Opin Organ Transplant, 13 (5), 506-12.
B cell-directed therapies for autoimmune disease and correlates of disease response and relapse
(2008). J Allergy Clin Immunol, 121 (1), 13-21. http://dx.doi.org/10.1016/j.jaci.2007.11.030, PMID: 18206502
Levesque MC, St Clair EW.
[Reprint] [PubMed]
[Citation View]
Levesque MC, St Clair EW. (2008). B cell-directed therapies for autoimmune disease and correlates of disease response and relapse. J Allergy Clin Immunol, 121 (1), 13-21.
Human CD4+CD25low Adaptive T Regulatory Cells Suppress Delayed-Type Hypersensitivity during Transplant Tolerance
(2007). J Immunol, 178 (6), 3983-95. , PMID: 17339499
Xu Q, Lee J, Jankowska-Gan E, Schultz J, Roennburg DA, Haynes LD, Kusaka S, Sollinger HW, Knechtle SJ, Vanbuskirk AM, Torrealba JR, Burlingham WJ
[Reprint] [PubMed]
[Citation View]
Xu Q, Lee J, Jankowska-Gan E, Schultz J, Roennburg DA, Haynes LD, Kusaka S, Sollinger HW, Knechtle SJ, Vanbuskirk AM, Torrealba JR, Burlingham WJ (2007). Human CD4+CD25low Adaptive T Regulatory Cells Suppress Delayed-Type Hypersensitivity during Transplant Tolerance. J Immunol, 178 (6), 3983-95.
Dendritic cell type determines the mechanism of bystander suppression by adaptive T regulatory cells specific for the minor antigen HA-1
(2007). J Immunol, 179 (6), 3443-51. , PMID: 17785778
Derks RA, Jankowska-Gan E, Xu Q, Burlingham WJ
[Reprint] [PubMed]
[Citation View]
Derks RA, Jankowska-Gan E, Xu Q, Burlingham WJ (2007). Dendritic cell type determines the mechanism of bystander suppression by adaptive T regulatory cells specific for the minor antigen HA-1. J Immunol, 179 (6), 3443-51.
Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding
(2007). J Allergy Clin Immunol, 120 (3), 688-95. , PMID: 17631952
Klunker S, Saggar LR, Seyfert-Margolis V, Asare AL, Casale TB, Durham SR, Francis JN, Immune Tolerance Network Group
[Reprint] [PubMed]
[Citation View]
Klunker S, Saggar LR, Seyfert-Margolis V, Asare AL, Casale TB, Durham SR, Francis JN, Immune Tolerance Network Group (2007). Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding. J Allergy Clin Immunol, 120 (3), 688-95.
HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4DQB1*0302 DAISY population
(2007). Diabetes, 56 (9), 2405-2409. , PMID: 17513705
Baschal EE, Aly TA, Babu SR, Fernando MS, Yu L, Miao D, Barriga KJ, Norris JM, Noble JA, Erlich HA, Rewers MJ, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Baschal EE, Aly TA, Babu SR, Fernando MS, Yu L, Miao D, Barriga KJ, Norris JM, Noble JA, Erlich HA, Rewers MJ, Eisenbarth GS (2007). HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4DQB1*0302 DAISY population. Diabetes, 56 (9), 2405-2409.
Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays
(2007). Clin Immunol, 125 (2), 120-126. , PMID: 17904423, PMCID: PMC2104491
Liu E, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Liu E, Eisenbarth GS (2007). Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol, 125 (2), 120-126.
Prevelence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity
(2007). J Clin Endocrinol, 92 (1), 88-92. , PMID: 17062766
Wang J, Miao D, Babu S, Yu J, Barker J, Klingensmith G, Rewers M, Eisenbarth GS, Yu L
[Reprint] [PubMed]
[Citation View]
Wang J, Miao D, Babu S, Yu J, Barker J, Klingensmith G, Rewers M, Eisenbarth GS, Yu L (2007). Prevelence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol, 92 (1), 88-92.
Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with standard ELISA
(2007). J Rheumatol, 34 (4), 734-739. , PMID: 17407230
Yu L, Wang J, O'Dell JR, Oates J, Arend WP, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Yu L, Wang J, O'Dell JR, Oates J, Arend WP, Eisenbarth GS (2007). Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with standard ELISA. J Rheumatol, 34 (4), 734-739.
A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1
(2007). Clin Immunol, 125 (2), 131-137. , PMID: 17825626, PMCID: PMC2080870
Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS
[Reprint] [PubMed]
[Citation View]
Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS (2007). A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin Immunol, 125 (2), 131-137.
Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus
(2007). J Leukoc Biol, 81 (3), 654-662. , PMID: 17151140
Kis J, Engelmann P, Farkas K, Richman G, Eck S, Lolley J, Jalahej H, Borowiec M, Kent SC, Treszl A, Orban T.
[Reprint] [PubMed]
[Citation View]
Kis J, Engelmann P, Farkas K, Richman G, Eck S, Lolley J, Jalahej H, Borowiec M, Kent SC, Treszl A, Orban T. (2007). Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus. J Leukoc Biol, 81 (3), 654-662.
Multi-SNP analysis of MHC region: Remarkable conservation of HLA-A1-B8-DR3 haplotype
(2006). Diabetes, 55 (5), 1265-1269. , PMID: 16644681
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR
[Reprint] [PubMed]
[Citation View]
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR (2006). Multi-SNP analysis of MHC region: Remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes, 55 (5), 1265-1269.
Extreme genetic risk for type 1A diabetes
(2006). Proc Natl Acad Sci, 103 (38), 14074-14079. , PMID: 16966600, PMCID: PMC1563993
Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS
[Reprint] [PubMed]
[Citation View]
Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS (2006). Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci, 103 (38), 14074-14079.
Omalizumab pretreatment decreases acute reactions following rush immunotherapy for ragweed-induced seasonal allergic rhinitis
(2006). J Allergy Clin Immunol, 117 (1), 134-140. , PMID: 16387596
Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Deniz Y, Immune Tolerance Network
[Reprint] [PubMed]
[Citation View]
Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Deniz Y, Immune Tolerance Network (2006). Omalizumab pretreatment decreases acute reactions following rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol, 117 (1), 134-140.
Immunotherapy with a ragweed–toll-like receptor 9 agonist vaccine for allergic rhinitis
(2006). New Engl J Med, 355 (14), 1445-1455. , PMID: 17021320
Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, Broide D, Immune Tolerance Network Group
[PubMed]
[Citation View]
Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, Broide D, Immune Tolerance Network Group (2006). Immunotherapy with a ragweed–toll-like receptor 9 agonist vaccine for allergic rhinitis. New Engl J Med, 355 (14), 1445-1455.
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses
(2006). Am J Transplant, 6 (9), 2121-2133. , PMID: 16796719
Fudaba Y, Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, Preffer F, Tolkoff-Rubin N, Dey BR, Saidman Sl, Kraus A, Bonnefoix T, McAfee S, Power K, Kattleman K, Colvin RB, Sachs DH, Cosimi AB, Sykes M
[Reprint] [PubMed]
[Citation View]
Fudaba Y, Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, Preffer F, Tolkoff-Rubin N, Dey BR, Saidman Sl, Kraus A, Bonnefoix T, McAfee S, Power K, Kattleman K, Colvin RB, Sachs DH, Cosimi AB, Sykes M (2006). Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant, 6 (9), 2121-2133.
Analysis of T cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study
(2006). Diabetes, 55 (9), 2588-2594. , PMID: 16936208
Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC
[Reprint] [PubMed]
[Citation View]
Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC (2006). Analysis of T cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes, 55 (9), 2588-2594.
The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses
(2006). J Immunol Meth, 317 (1-2), 71-79. , PMID: 17070537, PMCID: PMC1934503
Shamji MH, Wilcock LK, Wachholz PA, Dearman RJ, Kimber I, Wurtzen PA, Larché M, Durham SR, Francis JN
[Reprint] [PubMed]
[Citation View]
Shamji MH, Wilcock LK, Wachholz PA, Dearman RJ, Kimber I, Wurtzen PA, Larché M, Durham SR, Francis JN (2006). The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. J Immunol Meth, 317 (1-2), 71-79.
International trial of the Edmonton protocol for islet transplantation
(2006). New Engl J Med, 355 (13), 1318-1330. , PMID: 17005949
Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR
[Reprint] [PubMed]
[Citation View]
Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR (2006). International trial of the Edmonton protocol for islet transplantation. New Engl J Med, 355 (13), 1318-1330.
A highly immunogenic trivalent T cell receptor peptide vaccine
(2005). Multiple Sclerosis, 11 (5), 552-561. , PMID: 16193893
Bourdette DN, Edmonds E, Smith C, Bowen JD, Guttmann CR, Nagy ZP, Simon J, Whitham R, Lovera J, Yadav V, Mass M, Spencer L, Culbertson N, Bartholomew RM, Theofan G, Milano J, Offner H, Vandenbark AA
[Reprint] [PubMed]
[Citation View]
Bourdette DN, Edmonds E, Smith C, Bowen JD, Guttmann CR, Nagy ZP, Simon J, Whitham R, Lovera J, Yadav V, Mass M, Spencer L, Culbertson N, Bartholomew RM, Theofan G, Milano J, Offner H, Vandenbark AA (2005). A highly immunogenic trivalent T cell receptor peptide vaccine. Multiple Sclerosis, 11 (5), 552-561.
Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells
(2005). J Exp Med, 201 (7), 1031-1036. , PMID: 15795239, PMCID: PMC2213133
Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk HD, Lehmkuhl H, Kern F
[Reprint] [PubMed]
[Citation View]
Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk HD, Lehmkuhl H, Kern F (2005). Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells. J Exp Med, 201 (7), 1031-1036.
Persistence of herpes simplex virus type 2 VP16-specific CD4(+) T cells
(2005). Hum Immunol, 66 (7), 777-787. , PMID: 16112025
Danke NA, Koelle DM, Kwok WW
[Reprint] [PubMed]
[Citation View]
Danke NA, Koelle DM, Kwok WW (2005). Persistence of herpes simplex virus type 2 VP16-specific CD4(+) T cells. Hum Immunol, 66 (7), 777-787.
Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro
(2005). Am J Transplant, 5 (3), 454-464. , PMID: 15707399
Game DS, Hernandez-Fuentes MP, Lechler RI
[Reprint] [PubMed]
[Citation View]
Game DS, Hernandez-Fuentes MP, Lechler RI (2005). Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro. Am J Transplant, 5 (3), 454-464.
Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane
(2005). J Immunol, 174 (6), 3204-3211. , PMID: 15749850
Giannoni F, Barnett J, Bi K, Samodal R, Lanza P, Marchese P, Billetta R, Vita R, Klein MR, Prakken B, Kwok WW, Sercarz E, Altman A, Albani S
[Reprint] [PubMed]
[Citation View]
Giannoni F, Barnett J, Bi K, Samodal R, Lanza P, Marchese P, Billetta R, Vita R, Klein MR, Prakken B, Kwok WW, Sercarz E, Altman A, Albani S (2005). Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane. J Immunol, 174 (6), 3204-3211.
Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2
(2005). J Infect Dis, 191 (2), 243-254. , PMID: 15609235, PMCID: PMC1255909
Gonzalez JC, Kwok WW, Wald A, McClurkan CL, Huang J, Koelle DM
[Reprint] [PubMed]
[Citation View]
Gonzalez JC, Kwok WW, Wald A, McClurkan CL, Huang J, Koelle DM (2005). Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2. J Infect Dis, 191 (2), 243-254.
Decreased Foxp3 levels in multiple sclerosis patients
(2005). J Neurosci Res, 81 (1), 45-52. , PMID: 15952173
Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA
[Reprint] [PubMed]
[Citation View]
Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA (2005). Decreased Foxp3 levels in multiple sclerosis patients. J Neurosci Res, 81 (1), 45-52.
Functional avidity directs T-cell fate in autoreactive CD4+ T-cells
(2005). Blood, 106 (8), 2798-2805. , PMID: 16030184, PMCID: PMC1895305
Mallone R, Kochik SA, Reijonen H, Carson B, Ziegler SF, Kwok WW, Nepom GT
[Reprint] [PubMed]
[Citation View]
Mallone R, Kochik SA, Reijonen H, Carson B, Ziegler SF, Kwok WW, Nepom GT (2005). Functional avidity directs T-cell fate in autoreactive CD4+ T-cells. Blood, 106 (8), 2798-2805.
Messenger RNA for FOXP3 in the urine of renal allograft recipients
(2005). New Engl J Med, 353 (22), 2342-2351. , PMID: 16319383
Muthukumar T, Dadhania D, Ding R, Snopkowski C, Nagvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M
[Reprint] [PubMed]
[Citation View]
Muthukumar T, Dadhania D, Ding R, Snopkowski C, Nagvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M (2005). Messenger RNA for FOXP3 in the urine of renal allograft recipients. New Engl J Med, 353 (22), 2342-2351.
Congruent effects of estrogen and T cell receptor peptide therapy on regulatory T cells in EAE and MS
(2005). Intl Rev Immunol, 24 (5-6), 447-477. , PMID: 16318990
Offner H, Vandenbark AA
[PubMed]
[Citation View]
Offner H, Vandenbark AA (2005). Congruent effects of estrogen and T cell receptor peptide therapy on regulatory T cells in EAE and MS. Intl Rev Immunol, 24 (5-6), 447-477.
TCR peptide vaccination in multiple sclerosis: boosting a deficient natural regulatory network that may involve TCR-specific CD4
(2005). Curr Drug Targets Inflamm Allergy, 4 (2), 217-229. , PMID: 15853744
Vandenbark AA
[PubMed]
[Citation View]
Vandenbark AA (2005). TCR peptide vaccination in multiple sclerosis: boosting a deficient natural regulatory network that may involve TCR-specific CD4. Curr Drug Targets Inflamm Allergy, 4 (2), 217-229.
Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY)
(2004). J Clin Endocrinol Metab, 89 (8), 3896-3902. , PMID: 15292324
Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, Eisenbarth GS, Rewers M, Diabetes Autoimmunity Study in the Young
[Reprint] [PubMed]
[Citation View]
Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, Eisenbarth GS, Rewers M, Diabetes Autoimmunity Study in the Young (2004). Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab, 89 (8), 3896-3902.
Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up
(2004). Diabetes Care, 27 (6), 1399-1404. , PMID: 15161795
Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M, DAISY Study
[Reprint] [PubMed]
[Citation View]
Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M, DAISY Study (2004). Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care, 27 (6), 1399-1404.
Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation
(2004). Transplantation, 78 (1), 172-173. , PMID: 15257060
Brennan DC, Shannon MB, Koch MJ, Polonsky KS, Desai N, Shapiro J
[Reprint] [PubMed]
[Citation View]
Brennan DC, Shannon MB, Koch MJ, Polonsky KS, Desai N, Shapiro J (2004). Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation, 78 (1), 172-173.
Autoreactive T cells in healthy individuals
(2004). J Immunol, 172 (10), 5967-5972. , PMID: 15128778
Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW
[Reprint] [PubMed]
[Citation View]
Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW (2004). Autoreactive T cells in healthy individuals. J Immunol, 172 (10), 5967-5972.
Differential recognition and activation thresholds in human autoreactive GAD-specific T-cells
(2004). Diabetes, 53 (4), 971-977. , PMID: 15047612
Mallone R, Kochik SA, Laughlin EM, Gersuk VH, Reijonen H, Kwok WW, Nepom GT
[Reprint] [PubMed]
[Citation View]
Mallone R, Kochik SA, Laughlin EM, Gersuk VH, Reijonen H, Kwok WW, Nepom GT (2004). Differential recognition and activation thresholds in human autoreactive GAD-specific T-cells. Diabetes, 53 (4), 971-977.
Extensive replicative capacity of human central memory T cells
(2004). J Immunol, 172 (11), 6675-6683. , PMID: 15153483
Maus MV, Kovacs B, Kwok WW, Nepom GT, Schlienger K, Riley JL, Allman D, Finkel TH, June CH
[Reprint] [PubMed]
[Citation View]
Maus MV, Kovacs B, Kwok WW, Nepom GT, Schlienger K, Riley JL, Allman D, Finkel TH, June CH (2004). Extensive replicative capacity of human central memory T cells. J Immunol, 172 (11), 6675-6683.